N2,N4-bis(4-(piperazine-1-yl)phenyl)pirimidine-2,4-diamine derivative or pharmaceutically acceptable salt thereof, and composition containing same as active ingredient for preventing or treating cancer
Lee, Kwangho,Kim, Hyoung Rae,Park, Chi Hoon,Lee, Chong Ock,Lee, Jong Kook,Jung, Hee Jung,Cho, Sung Yun,Chae, Chong Hak,Choi, Sang Un,Ha, Jae Du
申请号：
AU2013300344
公开号：
AU2013300344A1
申请日:
2013.05.30
申请国别(地区):
AU
年份:
2015
代理人:
摘要：
The present invention relates to a N2,N4-bis(4-(piperazine-1-yl)phenyl)pirimidine-2,4-diamine derivative or a pharmaceutically acceptable salt thereof, and to a composition containing same as an active ingredient for preventing or treating cancer. Since the compound according to the present invention has good effects in inhibiting the activities of anaplastic lymphoma kinase (ALK) and activated Cdc42-associated kinase (ACK1), the compound can have improved therapeutic effects against cancer cells having ALK fusion proteins such as EML4-ALK and NPM-ALK and is expected to be effective in preventing the recurrence of cancer. Therefore, the compound can be effectively used as a composition for preventing or treating cancer.
